| P2093 | author name string | Xiaolu Cui | |
| | Chiyuan Piao | |
| | Chuize Kong | |
| | Xuyong Lin | |
| | Xiaojun Man | |
| | Yuanjun Jiang | |
| P2860 | cites work | Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. | Q38876950 |
| | The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network | Q39948774 |
| | Improving microRNA target prediction by modeling with unambiguously identified microRNA-target pairs from CLIP-ligation studies | Q40130973 |
| | Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. | Q40615729 |
| | The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity | Q40805561 |
| | Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway | Q40817321 |
| | Nongenomic Mechanisms of PTEN Regulation | Q42218359 |
| | Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1. | Q44204596 |
| | MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells | Q45872881 |
| | The tumor suppressor phosphatase and tensin homolog protein (PTEN) is negatively regulated by NF-κb p50 homodimers and involves histone 3 methylation/deacetylation in UROtsa cells chronically exposed to monomethylarsonous acid | Q47930560 |
| | Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients. | Q54583947 |
| | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 |
| | High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral | Q85804519 |
| | Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 | Q90903275 |
| | Ubiquitination regulates PTEN nuclear import and tumor suppression | Q24292946 |
| | The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 |
| | Regulation of MITF stability by the USP13 deubiquitinase | Q24318832 |
| | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| | Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13 | Q24338972 |
| | MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 |
| | PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 |
| | Regulation of ubiquitin-dependent processes by deubiquitinating enzymes | Q28257517 |
| | Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 |
| | MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer | Q29617772 |
| | NF-kappaB at the crossroads of life and death | Q29619302 |
| | PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit | Q30308560 |
| | starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data | Q30705717 |
| | USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response | Q33770883 |
| | Suppression of PTEN expression by NF-kappa B prevents apoptosis | Q35544303 |
| | The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies | Q35638497 |
| | Focus on bladder cancer | Q35868630 |
| | Urothelial tumorigenesis: a tale of divergent pathways | Q36234720 |
| | PTEN at a glance | Q36452913 |
| | Post-translational regulation of PTEN. | Q37270440 |
| | Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif | Q37403837 |
| | Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene | Q37457770 |
| | Amplification of USP13 drives ovarian cancer metabolism | Q37465116 |
| | miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression | Q37565531 |
| | Deubiquitylation and stabilization of PTEN by USP13 | Q37633952 |
| | Molecular analysis of PTEN and MXI1 in primary bladder carcinoma | Q38307065 |
| | UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. | Q38667837 |
| | A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now. | Q38755773 |
| P433 | issue | 1 | |
| P304 | page(s) | 259 | |
| P577 | publication date | 2019-06-14 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. | |
| P478 | volume | 38 | |